Octapharma Pharmazeutika Produktionsgesellschaft M.B.H. FDA Inspection Record

FEI 3002809097 · Inspections, Form 483s, warning letters and import refusals

Octapharma Pharmazeutika Produktionsgesellschaft M.B.H. is an FDA-registered facility (FEI 3002809097) located in A-1100, AT. Registered operations: ANALYSIS; LABEL; MANUFACTURE; PACK. RegDataLab tracks 5 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Dec 16, 2022: Voluntary Action Indicated (VAI)
Inspections on record
5 (5 VAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Form 483 and inspection documents
1 in FDA's reading room
Recalls as the recalling firm
1, latest Aug 11, 2025
Import refusals
1

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Dec 16, 2022Voluntary Action Indicated (VAI)No citations listed
Apr 16, 2019Voluntary Action Indicated (VAI)No citations listed
Jan 17, 2017Voluntary Action Indicated (VAI)No citations listed
Mar 5, 2015Voluntary Action Indicated (VAI)No citations listed
Dec 18, 2012Voluntary Action Indicated (VAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Aug 11, 2025Class IIB-0152-2026Immune Globulin (Human); Octagam IVIG 10% 30gm/300mL (Batch KP12B8561)
Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. is recalling distributed Octagam IVIG 10% 30gm/300mL (Batch KP12B8561) as they fell…

Form 483s and inspection documents

  • 483 on FDA.gov
    FDA listing date Dec 16, 2022, which is not always the inspection or issue date. Published by FDA Oct 26, 2026.

FDA record score

11 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 15, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

6 records behind this number
RecordDatePoints x age weightAdds
Class II recall B-0152-2026, this FEI as the recalling firmAug 11, 20254 x 14
Inspection classified VAIDec 16, 20226 x 0.63.6
Inspection classified VAIApr 16, 20196 x 0.251.5
Inspection classified VAIJan 17, 20176 x 0.251.5
Inspection classified VAIMar 5, 201510 years or older, so it adds no points0
Inspection classified VAIDec 18, 201210 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 15, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 15, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 14, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 15, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Octapharma Pharmazeutika Produktionsgesellschaft M.B.H. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Octapharma Pharmazeutika Produktionsgesellschaft M.B.H. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Octapharma Pharmazeutika Produktionsgesellschaft M.B.H.
Location
A-1100 (AT)
Registration Expires
Dec 31, 2026
Operations
ANALYSIS; LABEL; MANUFACTURE; PACK
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.